Related Experiment Video
Updated: Aug 12, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Raised D-dimer among Admitted COVID-19 Patients in a Tertiary Care Centre: A Descriptive Cross-sectional Study
Dipesh Karki1, Roshani Gurung2, Prasanna Nepali3
1Department of Medicine, Fishtail Hospital and Research Center Private Limited, Pokhara, Kaski, Nepal.
Insights
The prevalence of elevated D-dimer in hospitalized COVID-19 patients was 47.22%. This finding for D-dimer levels in COVID-19 patients was lower than in other similar studies.
Area of Science:
- Medical Research
- Infectious Diseases
- Hematology
Background:
- COVID-19 is associated with abnormal inflammatory biomarkers, including elevated D-dimer.
- Elevated D-dimer levels in COVID-19 patients correlate with increased mortality risk.
Purpose of the Study:
- To determine the prevalence of elevated D-dimer in COVID-19 patients admitted to a tertiary care center.
Main Methods:
- A descriptive cross-sectional study was conducted between January and June 2021.
- Data on D-dimer levels and demographics were collected from 180 hospitalized COVID-19 patients.
- Convenience sampling and calculation of point estimates with 95% Confidence Intervals were employed.
Main Results:
- Out of 180 COVID-19 patients, 85 (47.22%) exhibited elevated D-dimer levels.
- The 95% Confidence Interval for the prevalence was 39.93% to 54.51%.
Conclusions:
- The prevalence of raised D-dimer among admitted COVID-19 patients in this tertiary care center was 47.22%.
- This prevalence was observed to be lower compared to findings in similar studies.
Introduction:
Patients with COVID-19 are characterised by abnormal levels of inflammatory biomarkers. Elevated D-dimer in COVID-19 patients is associated with increased mortality. This study aimed to find out the prevalence of raised D-dimer among COVID-19 patients in a tertiary care centre.
Methods:
This descriptive cross-sectional study was conducted in COVID-19 unit of a tertiary care centre from 23 January 2021 to 19 June 2021. The ethical approval was taken from the Institutional Review Committee (Reference number: 077/078/159). D-dimer values and demographic data of the hospital-admitted COVID-19 patients were recorded. Convenience sampling technique was used. Point estimate and 95% Confidence Interval were calculated.
Results:
Out of 180 patients with COVID-19 admitted in the hospital, the D-dimer levels were raised in 85 (47.22%) (39.93-54.51, 95% Confidence Interval) patients.
Conclusions:
The prevalence of raised D-dimer among admitted COVID-19 patients was found to be lower when compared to other studies conducted in similar settings.
Keywords:
COVID-19; D-dimer; Nepal; prevalence.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pneumonia III: Complications and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism I: Introduction